drugset / Trial / NCT03130452
Helicobacter Pylori Eradication Study
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study was to evaluate the efficacy and compliance of tailored therapy which using the polymerase chain reaction for point mutation of clarithromycin, compared to concomitant therapy, in patients without history of H. pylori eradication.
Timeline
- Start
- 2016-12-17
- Primary completion
- 2019-01-28
- Completion
- 2019-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amoxicillin | Other / unclassified | 1 g | Oral |
| Subject | Clarithromycin | Small molecule | 500 mg | Oral |
| Subject | Lansoprazole | Other / unclassified | 30 mg | Oral |
| Subject | Metronidazole | Small molecule | 500 mg | Oral |